Design Therapeutics, Inc. Other Current Assets
Design Therapeutics, Inc. (DSGN) had Other Current Assets of $236.00 thousand as of 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2022-11-03
- 2022-06-30: Other Assets, Current $236.00K.
- 2022-03-31: Other Assets, Current $112.00K.
- 2021-12-31: Other Assets, Current $7.00K.
- 2020-12-31: Other Assets, Current $25.00K.
| Period end | Other Assets, Current |
|---|---|
| 2022-06-30 | $236.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $112.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | $7.00K 10-Q · filed 2022-11-03 |
| 2020-12-31 | $25.00K 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |